Submit Deal

FAGRON NV/BV

Summary

Fagron NV provides pharmaceutical compounding services to hospitals, pharmacies, clinics, and patients worldwide.

Deals Overview

Total Deals6

Valued Deals2

Total Value£40M

Avg. Deal Size£20M

Market Context

Senior Management

Rafael Padilla
CEO
Karin de Jong
CFO
Karin de Jong
CFO

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Senior Management

Rafael Padilla
CEO
Karin de Jong
CFO
Karin de Jong
CFO

Deals (6)

Service Providers

Relationships

Portfolio

Team

Sort

Belgium

IT Services: Other

DisposalPrivateMboPrivate Equity

target

Corilus

bidder

Aac Capital Partners Holding

value n/a

0 dealmakers

Mexico

Pharmaceuticals

PrivateAcquisition

target

Central De Drogas De Cv

bidder

Fagron Nv/bv

£14m

1 dealmaker

United States

Pharmaceuticals

PrivateCross BorderMajorityAcquisition

target

Letco Medical

bidder

Fagron Nv/bv

£25m

5 dealmakers

Germany

Pharmaceuticals

Cross BorderMajorityPrivateAcquisition

target

Fresenius Kabi

bidder

Fagron Nv/bv

value n/a

20 dealmakers

Germany

Biotechnology

Private EquityAcquisitionPrivateMajorityCross Border

target

Hiperscan

bidder

Fagron Nv/bv

value n/a

8 dealmakers

United Kingdom

Pharmaceuticals

AcquisitionCross BorderMajorityPrivate

target

Specialist Pharmacy

bidder

Fagron Nv/bv

value n/a

10 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy